Humacyte (NASDAQ:HUMA) reported its Q3 earnings results on Thursday, November 9, 2023 at 04:01 PM.
Here’s what investors need to know about the announcement.
Earnings
Humacyte reported in-line EPS of $-0.25 versus an estimate of $-0.25.
Revenue was down $31 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 10.89% increase in the share price the next day.
Here’s a look at Humacyte’s past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.22 | -0.21 | -0.23 | -0.21 |
| EPS Actual | -0.22 | -0.36 | -0.04 | -0.25 |
| Revenue Estimate | 70K | 170K | 200K | 200K |
| Revenue Actual | 0 | 0 | 0 | 31K |
To track all earnings releases for Humacyte visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
